Inhibition or knockdown of EGFR greatly attenuated the increased FZD5, p-p38, and p-ERK levels, and the pro-fibrotic effect induced by Wnt5a or Wnt11 in CFs. The gene discussed is WNT5A; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.